To promote the interests of people affected by MS (Multiple Sclerosis).
1. Lemtrada (alemtuzumab) and serious cardiovascular and immune-mediated adverse reactions: new restrictions to use and strengthened monitoring requirements
17/05/2019 - Medicines and Healthcare products Regulatory Agency (MHRA)
- View source
Found: treatment. All patients on alemtuzumab for multiple sclerosis should be alerted to these risks and what
2. Ms H Rawlins v Multiple Sclerosis Society: 2206532/2018
31/12/2019 - HM Courts & Tribunals Service (HMCTS)
- View source
Found:
Ms H Rawlins v Multiple Sclerosis Society: 2206532/2018 - GOV.UK
3. Drug Safety Update: monthly PDF newsletter
21/11/2019 - Medicines and Healthcare products Regulatory Agency (MHRA)
- View source
Found: progressive multifocal
leu
koencephalopathy in a multiple sclerosis patient who had severe, prolonged
lymphopenia
4. Multiple sclerosis: prevalence, incidence and smoking status
04/02/2020 - Public Health England (PHE)
- View source
Found:
Research and analysis
Multiple sclerosis: prevalence, incidence and smoking status
5. Drug Safety Update: monthly PDF newsletter
21/11/2019 - Medicines and Healthcare products Regulatory Agency (MHRA)
- View source
Found: 201
7
Contents
Daclizumab
in multiple sclerosis now restricted, promptly review patients
1. Legalisation of Cannabis (Medicinal Purposes)
10/10/2017 - Commons Chamber
1: she was struck down at the age of 26 with multiple sclerosis, which virtually destroyed her life and affected - Speech Link
2. Maraviroc and Progressive Multifocal Leukoencephalopathy
30/09/2019 - Commons Chamber
1: clear.Ms Rai was sadly diagnosed with multiple sclerosis in 2013 aged 34. She was prescribed Natalizumab - Speech Link
2: immune reconstitution inflammatory syndrome in multiple sclerosis. An individual funding request was submitted - Speech Link
3: Lady’s constituent, who unfortunately has multiple sclerosis, has been paying privately for the drug, - Speech Link
3. Medical Cannabis
20/02/2018 - Commons Chamber
1: medicines for conditions associated with multiple sclerosis, the side-effects of chemotherapy, and epilepsy - Speech Link
2: suffering from the very final stages of multiple sclerosis. Her husband has found that the only drug - Speech Link
3: our party conference heard evidence from a multiple sclerosis sufferer, Laura Brennan-Whitefield, who called - Speech Link
4: different illnesses, such as epilepsy and multiple sclerosis. They told me that conventional drugs have - Speech Link
5: talked about and discuss the fact that the Multiple Sclerosis Society has changed its position on the use - Speech Link
4. Drugs Licensing
19/06/2018 - Lords Chamber
1: benefits for people suffering from cancer, multiple sclerosis, Tourette’s syndrome, chronic severe pain - Speech Link
2: cannabis-based medication for epilepsy and multiple sclerosis and as pain relief in some forms of terminal - Speech Link
3: of conditions. I worked with sufferers of multiple sclerosis for 10 years and the use of cannabis-derived - Speech Link
5. Medicinal Cannabis
06/07/2020 - Lords Chamber
1: capable of handling medical cannabis, which has multiple active ingredients and is therefore not suitable - Speech Link
2: them, Sativex—prescribed within the NHS for multiple sclerosis—has a high level of the active cannabinoid - Speech Link
6. Social Security and Employment Support for Disabled People
06/03/2019 - Commons Chamber
1: conditions such as motor neurone disease, multiple sclerosis and cancer—being exempted from repeat assessments - Speech Link
2: problems. The fact that 83% of people with multiple sclerosis who appeal their PIP case are successful - Speech Link
3: Specifically on the case of people with multiple sclerosis, or cases brought to me by people who feel - Speech Link
7. Toilets (Provision and Accessibility)
27/06/2018 - Commons Chamber
1: older people, 40,000 people with profound and multiple learning disabilities, 30,000 people with cerebral - Speech Link
8. Cannabis (Legalisation and Regulation)
23/03/2016 - Commons Chamber
1: cruel, unjust policy that is. We criminalise multiple sclerosis sufferers and many others who use cannabis - Speech Link
9. Drugs Policy: Departmental Responsibility
07/02/2017 - Lords Chamber
1: some of the increases in drug-related deaths are multiple and complex, which is why we established an expert - Speech Link
2: the value of Sativex in the treatment of multiple sclerosis and other types of pain relief. The MHRA - Speech Link
10. Cannabis-based Medication
21/02/2018 - Lords Chamber
1: I worked extensively with people who had multiple sclerosis, and I know that Sativex has been produced - Speech Link
Registered Contact:
Simon Hoare MP, House of Commons, London, SW1A 0AA. Tel: 020 7219 5697.
Email: simon.hoare.mp@parliament.uk
Public Enquiry Point:
Joe Brunwin, MS Society, 372 Edgware Road, London NW2 6ND. Tel: 07879 643 289
Email: joseph.brunwin@mssociety.org.uk
Secretariat:
MS Society acts as the group's secretariat. http://www.mssociety.org.uk/
No direct financial benefits are on record for the Multiple Sclerosis APPG